针对晚期或转移性癌症患者的专业主导型支持小组:在现实世界的医疗保健和社区环境中,对有效性和实施成功的关键因素进行系统的范围界定审查。

IF 3.1 2区 医学 Q2 ONCOLOGY
Journal of Cancer Survivorship Pub Date : 2025-06-01 Epub Date: 2024-01-08 DOI:10.1007/s11764-023-01515-w
Zhicheng Li, Kitty-Jean Laginha, Frances Boyle, Michele Daly, Fiona Dinner, Pia Hirsch, Kim Hobbs, Laura Kirsten, Carolyn Mazariego, Ros McAuley, Mary O'Brien, Amanda O'Reilly, Natalie Taylor, Lisa Tobin, Sophie Lewis, Andrea L Smith
{"title":"针对晚期或转移性癌症患者的专业主导型支持小组:在现实世界的医疗保健和社区环境中,对有效性和实施成功的关键因素进行系统的范围界定审查。","authors":"Zhicheng Li, Kitty-Jean Laginha, Frances Boyle, Michele Daly, Fiona Dinner, Pia Hirsch, Kim Hobbs, Laura Kirsten, Carolyn Mazariego, Ros McAuley, Mary O'Brien, Amanda O'Reilly, Natalie Taylor, Lisa Tobin, Sophie Lewis, Andrea L Smith","doi":"10.1007/s11764-023-01515-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To examine the effectiveness of professionally led support groups for people with advanced or metastatic cancer, and identify factors critical to implementation success within real-world settings.</p><p><strong>Methods: </strong>Databases (MEDLINE; PsychINFO; CINAHL) and grey literature were searched for empirical publications and evaluations. Articles were screened for eligibility and data systematically extracted, charted and summarised using a modified scoping review methodology. Implementation factors were mapped using Proctor's implementation framework and the Consolidated Framework for Implementation Research 2.0.</p><p><strong>Results: </strong>A total of 1691 publications were identified; 19 were eligible for inclusion (8 randomised controlled trials, 7 qualitative studies, 2 cohort studies, 2 mixed methods studies). Most (n=18) studies focused on tumour-specific support groups. Evidence supported professionally led support groups in reducing mood disturbances (n=5), distress (i.e. traumatic stress, depression) (n=4) and pain (n=2). Other benefits included social connectedness (n=6), addressing existential distress (n=5), information and knowledge (n=6), empowerment and sense of control (n=2), relationships with families (n=2) and communication with health professionals (n=2). Thirteen studies identified factors predicting successful adoption, implementation or sustainment, including acceptability (n=12; 63%), feasibility (n=6; 32%) and appropriateness (n=1; 5%). Key determinants of successful implementation included group leaders' skills/experience, mode of operation, travelling distance, group composition and membership and resourcing.</p><p><strong>Conclusions: </strong>Professionally led tumour-specific support groups demonstrate effectiveness in reducing mood disturbances, distress and pain among patients. Successful implementation hinges on factors such as leadership expertise, operational methods and resource allocation.</p><p><strong>Implications for cancer survivors: </strong>Professionally led support groups may fill an important gap in supportive care for people with advanced or metastatic cancer.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":"957-977"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081543/pdf/","citationCount":"0","resultStr":"{\"title\":\"Professionally led support groups for people living with advanced or metastatic cancer: a systematic scoping review of effectiveness and factors critical to implementation success within real-world healthcare and community settings.\",\"authors\":\"Zhicheng Li, Kitty-Jean Laginha, Frances Boyle, Michele Daly, Fiona Dinner, Pia Hirsch, Kim Hobbs, Laura Kirsten, Carolyn Mazariego, Ros McAuley, Mary O'Brien, Amanda O'Reilly, Natalie Taylor, Lisa Tobin, Sophie Lewis, Andrea L Smith\",\"doi\":\"10.1007/s11764-023-01515-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To examine the effectiveness of professionally led support groups for people with advanced or metastatic cancer, and identify factors critical to implementation success within real-world settings.</p><p><strong>Methods: </strong>Databases (MEDLINE; PsychINFO; CINAHL) and grey literature were searched for empirical publications and evaluations. Articles were screened for eligibility and data systematically extracted, charted and summarised using a modified scoping review methodology. Implementation factors were mapped using Proctor's implementation framework and the Consolidated Framework for Implementation Research 2.0.</p><p><strong>Results: </strong>A total of 1691 publications were identified; 19 were eligible for inclusion (8 randomised controlled trials, 7 qualitative studies, 2 cohort studies, 2 mixed methods studies). Most (n=18) studies focused on tumour-specific support groups. Evidence supported professionally led support groups in reducing mood disturbances (n=5), distress (i.e. traumatic stress, depression) (n=4) and pain (n=2). Other benefits included social connectedness (n=6), addressing existential distress (n=5), information and knowledge (n=6), empowerment and sense of control (n=2), relationships with families (n=2) and communication with health professionals (n=2). Thirteen studies identified factors predicting successful adoption, implementation or sustainment, including acceptability (n=12; 63%), feasibility (n=6; 32%) and appropriateness (n=1; 5%). Key determinants of successful implementation included group leaders' skills/experience, mode of operation, travelling distance, group composition and membership and resourcing.</p><p><strong>Conclusions: </strong>Professionally led tumour-specific support groups demonstrate effectiveness in reducing mood disturbances, distress and pain among patients. Successful implementation hinges on factors such as leadership expertise, operational methods and resource allocation.</p><p><strong>Implications for cancer survivors: </strong>Professionally led support groups may fill an important gap in supportive care for people with advanced or metastatic cancer.</p>\",\"PeriodicalId\":15284,\"journal\":{\"name\":\"Journal of Cancer Survivorship\",\"volume\":\" \",\"pages\":\"957-977\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081543/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer Survivorship\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11764-023-01515-w\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-023-01515-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/8 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:研究由专业人员领导的晚期或转移性癌症患者支持小组的有效性,并确定在实际环境中实施成功的关键因素:对数据库(MEDLINE;PsychINFO;CINAHL)和灰色文献进行了检索,以查找经验性出版物和评估。筛选符合条件的文章,采用修改后的范围界定综述方法系统地提取数据、绘制图表并进行总结。使用 Proctor 的实施框架和实施研究综合框架 2.0 对实施因素进行了映射:共确定了 1691 篇出版物,其中 19 篇符合纳入条件(8 篇随机对照试验、7 篇定性研究、2 篇队列研究、2 篇混合方法研究)。大多数研究(n=18)侧重于特定肿瘤支持小组。有证据表明,由专业人员领导的支持小组可减少情绪障碍(5 项)、痛苦(如创伤性压力、抑郁)(4 项)和疼痛(2 项)。其他益处包括社会联系(6 项)、解决生存困扰(5 项)、信息和知识(6 项)、授权和控制感(2 项)、与家人的关系(2 项)以及与医疗专业人员的沟通(2 项)。13 项研究确定了预测成功采用、实施或持续的因素,包括可接受性(12 项;63%)、可行性(6 项;32%)和适宜性(1 项;5%)。成功实施的关键决定因素包括小组领导者的技能/经验、运作模式、旅行距离、小组组成和成员以及资源:结论:由专业人士领导的肿瘤支持小组在减少患者的情绪障碍、痛苦和疼痛方面表现出了有效性。成功实施取决于领导者的专业知识、运作方法和资源分配等因素:由专业人士领导的支持小组可能会填补晚期或转移性癌症患者支持性护理方面的一个重要空白。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Professionally led support groups for people living with advanced or metastatic cancer: a systematic scoping review of effectiveness and factors critical to implementation success within real-world healthcare and community settings.

Purpose: To examine the effectiveness of professionally led support groups for people with advanced or metastatic cancer, and identify factors critical to implementation success within real-world settings.

Methods: Databases (MEDLINE; PsychINFO; CINAHL) and grey literature were searched for empirical publications and evaluations. Articles were screened for eligibility and data systematically extracted, charted and summarised using a modified scoping review methodology. Implementation factors were mapped using Proctor's implementation framework and the Consolidated Framework for Implementation Research 2.0.

Results: A total of 1691 publications were identified; 19 were eligible for inclusion (8 randomised controlled trials, 7 qualitative studies, 2 cohort studies, 2 mixed methods studies). Most (n=18) studies focused on tumour-specific support groups. Evidence supported professionally led support groups in reducing mood disturbances (n=5), distress (i.e. traumatic stress, depression) (n=4) and pain (n=2). Other benefits included social connectedness (n=6), addressing existential distress (n=5), information and knowledge (n=6), empowerment and sense of control (n=2), relationships with families (n=2) and communication with health professionals (n=2). Thirteen studies identified factors predicting successful adoption, implementation or sustainment, including acceptability (n=12; 63%), feasibility (n=6; 32%) and appropriateness (n=1; 5%). Key determinants of successful implementation included group leaders' skills/experience, mode of operation, travelling distance, group composition and membership and resourcing.

Conclusions: Professionally led tumour-specific support groups demonstrate effectiveness in reducing mood disturbances, distress and pain among patients. Successful implementation hinges on factors such as leadership expertise, operational methods and resource allocation.

Implications for cancer survivors: Professionally led support groups may fill an important gap in supportive care for people with advanced or metastatic cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.00
自引率
10.80%
发文量
149
审稿时长
>12 weeks
期刊介绍: Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信